See also this year's filing and all EDGAR filings for this company.
PDF Report 0001367920_2022_Concert_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001367920, Concert Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 150,329,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,242,000 |
| 3 | remainder_Assets | 9,745,000 |
| 4 | LiabilitiesCurrent | 16,120,000 |
| 5 | LiabilitiesNoncurrent | 21,505,000 |
| 6 | remainder_Liabilities | 15,466,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 23,005,137 |
| 9 | ResearchAndDevelopmentExpense | 90,435,507 |
| 10 | remainder_Expenses | 1,271,626 |
| 11 | remainder_Revenues | 18,441,766 |
| 12 | remainder_NetIncome | -231,364 |
| 13 | remainder_ComprehensiveNetIncome | 20,765 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 165,316,000 |
| 1 | Liabilities | 53,091,000 |
| 2 | Expenses | 114,712,270 |
| 3 | Revenues | 18,441,766 |
| 4 | StockholdersEquity | 112,225,000 |
| 5 | NetIncome | -96,501,868 |
| 6 | ComprehensiveNetIncome | -96,491,486 |
| 7 | BaseVar | 175,906,582 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.36 |
| 9 | EconomicCapitalRatio | 2.57 |
Edgar->Model Mapping
Feature Distribution
Change over Time
